BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023
BioSenic PRESS RELEASE – PRIVILEGED INFORMATION In view of the restructuring plan announced on April 11, 2024, BioSenic has decided to postpone the publication of its 2023 annual report as well as its annual general meeting of shareholders, so that the Enterprise Court of Nivelles can make a decision before the completion of the annual